Edwards Lifesciences (EW) stock: analyst price target and their real reliability
Live quote · data updated Aug 28, 2026
Edwards Lifesciences · Health Care · ref. ETF XLV · 74 calls · price $89.95
What the company does: Edwards Lifesciences Corporation provides products and technologies to treat advanced cardiovascular diseases in the United States, Europe, Japan, and internationally.
📈 Edwards Lifesciences (EW) stock price
$89.95+10.7% over range
Aug 28, 25low $72.65 · high $95.18Aug 27, 26
📏 Click 2 points (left → right) to measure the change · click again to clear.
SellBuy
Buy
77% recommend buying · 13 analysts
📊 JPI status : Edwards Lifesciences has never appeared in a JPI ranking (Fair or Risk +) — our methods haven't picked it to date. See the selected stocks →
🎯 EW price target & analyst consensus — price $89.95
The price target · all analysts combined (13 targets)
Highest target · 4 firms of 13$110+22.3%
Median target · of 13 targets$104+15.6%
Lowest target · 1 firm of 13$85-5.5%
Current price$89.95
Where these 13 targets sit · versus the current price · 1 target per firm, last 6 months
Above the price
1185%
$95 ↔ $110
Below
215%
$85 ↔ $87
⭐ What the most reliable analysts say
· those who beat their sector, targets replayed on real prices
⭐ The most reliable of them, either direction: JP Morgan — 67% of its targets hit on this sector (355 calls tested). It aims for $105 (+17 %), call made on July 25, 2026, maturing on July 25, 2027 (34 d ago).
The 8 reliable analysts
$105+16 %
The 5 other firms
$100+11 %
How to read it: the 8 reliable firms are not filtered by optimism — 8 aim above the price, 0 below, hence their $105 median. “The 5 others” are the firms that don't pass our reliability filter on this sector.
The consensus · 13 ratings (last 6 months)
Strong Buy00%
Buy1077%
Hold323%
Sell00%
Strong Sell00%
Go deeper on the analysts
🎯 EW price target all
All 74 calls, one by one, with our verdict on each firm.
→ See all 74 targets, analyst by analyst💡 The best analysts on EW most reliable
The case for and against, with the numbers, per those who've been right on the stock.
→ Should you invest in EW? The case for & againstAll analysts (the consensus) · vs · the best (those who've been right)
💬 A question about Edwards Lifesciences? The JPI assistant answers using our backtest data.
📈 Edwards Lifesciences fundamentals: valuation, margins & growth › open the full page
P/E 54.2Net margin 15.4 %Revenue growth +13.6 %Fairly valued
Revenue, net income and margin per year
Revenue Net income · hover a bar for details
2022
marg. 28 %
2023
Rev +12%Profit −8%
2024
Rev −9%Profit +198%
2025
Rev +12%Profit −74%
🔎 Detailed analyses
✅ Historical analyst reliability on EW
Hit rate measured on targets already matured (12 months), replayed against real prices. Click a header to sort.
| Firm ↕ | % right i ↕ | Gain vs sector i ↕ | Calls i ↕ |
|---|---|---|---|
| CRT Capital | 100% | +67.7% | 2 |
| JMP Securities | 100% | +35.3% | 4 |
| Cowen & Co. | 100% | +34.9% | 3 |
| Evercore ISI Group ↗ | 100% | +32.8% | 2 |
| Northland Capital Markets ↗ | 100% | +27.4% | 3 |
| Stifel ↗ | 88% | +24.1% | 16 |
| Credit Suisse | 83% | +13.9% | 18 |
| BMO Capital ↗ | 75% | +22.6% | 4 |
| Wells Fargo ↗ | 71% | +11.3% | 17 |
| B of A Securities ↗ | 67% | +5.5% | 6 |
See the other 20 firms
| Wolfe Research ↗ | 0% | -23.6% | 3 |
| JP Morgan ↗ | 17% | -17.9% | 6 |
| Truist Securities ↗ | 31% | -6.1% | 13 |
| UBS ↗ | 33% | -19.1% | 3 |
| Citigroup ↗ | 33% | -7.1% | 27 |
| RBC Capital ↗ | 33% | -3.4% | 21 |
| Jefferies ↗ | 33% | 0.0% | 12 |
| Goldman Sachs ↗ | 38% | -1.6% | 8 |
| SVB Leerink | 40% | +0.4% | 10 |
| BTIG ↗ | 50% | -4.9% | 2 |
| Bernstein ↗ | 50% | -1.8% | 2 |
| Oppenheimer ↗ | 50% | +1.4% | 4 |
| CFRA | 50% | +9.6% | 2 |
| Mizuho ↗ | 56% | -4.6% | 9 |
| Canaccord Genuity ↗ | 56% | +15.0% | 16 |
| Raymond James ↗ | 58% | +7.9% | 19 |
| Morgan Stanley ↗ | 59% | +10.6% | 34 |
| Barclays ↗ | 62% | +2.8% | 13 |
| Piper Sandler ↗ | 62% | +5.7% | 16 |
| Deutsche Bank ↗ | 67% | +5.0% | 3 |
📊 What $1,000 invested in Edwards Lifesciences would be worth › open the full page
In short — $1,000 invested in Edwards Lifesciences 10 years ago would be worth $3,436 today, i.e. +13%/yr on average. Best year: 2019 (+52%), worst: 2022 (-42%). Price performance, excluding dividends.
If I'd invested $1,000 in Edwards Lifesciences
| Investment | Worth today | Gain |
|---|---|---|
| 1 years ago | $1,222 | +22% |
| 3 years ago | $1,212 | +21% |
| 5 years ago | $992 | -1% |
Return by year (Edwards Lifesciences)
| Year | Return | $1,000 invested at year start |
|---|---|---|
| 2026 (YTD) | +6% | $1,061 (+6%) |
| 2025 | +15% | $1,222 (+22%) |
| 2024 | -3% | $1,186 (+19%) |
⚠️ Past performance, not predictive nor advice. Prices in $, excluding dividends. Yahoo Finance data.
📰 Recent news on Edwards Lifesciences
Loading news…
📋 All analyst calls on EW
Filtered on — · ✕ show all
Leerink Partners ↗
Jul 25, 26
▲ Outperform · 🎯$101
Price at call : $83.04 — upside +22%
Today : $89.95 — upside +12%
🎯 on EW : no call matured yet · 📊 on Health : 55.3% · -4.8% (38 calls)
in progress (365j)
matures : Jul 25, 27
matures : Jul 25, 27
▲ Overweight · 🎯$105
Price at call : $83.04 — upside +26%
Today : $89.95 — upside +17%
🎯 on EW : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Jul 24, 27
matures : Jul 24, 27
Piper Sandler ↗
Jul 24, 26
▲ Overweight · 🎯$101
Price at call : $83.04 — upside +22%
Today : $89.95 — upside +12%
🎯 on EW : no call matured yet · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Jul 24, 27
matures : Jul 24, 27
Truist Securities ↗
Jul 16, 26
■ Hold neutral · not a buy · 🎯$95
Price at call : $85.73 — gap to target +11%
Today : $89.95 — gap to target +6%
🎯 on EW : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Jul 16, 27
matures : Jul 16, 27
▲ Outperform · 🎯$105
Price at call : $87.84 — upside +20%
Today : $89.95 — upside +17%
🎯 on EW : no call matured yet · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : Jul 15, 27
matures : Jul 15, 27
RBC Capital ↗
Jul 13, 26
▲ Outperform · 🎯$110
Price at call : $90.09 — upside +22%
Today : $89.95 — upside +22%
🎯 on EW : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Jul 13, 27
matures : Jul 13, 27
▲ Buy · 🎯$110
Price at call : $93.64 — upside +17%
Today : $89.95 — upside +22%
🎯 on EW : 42% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Jul 8, 27
matures : Jul 8, 27
Evercore ISI Group ↗
Jul 6, 26
▲ Outperform · 🎯$100
Price at call : $94.82 — upside +5%
Today : $89.95 — upside +11%
🎯 on EW : no call matured yet · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Jul 6, 27
matures : Jul 6, 27
See the other 66 calls, newest to oldest
▲ Buy · 🎯$110
Price at call : $90.46 — upside +22%
Today : $89.95 — upside +22%
🎯 on EW : no call matured yet · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Jun 30, 27
matures : Jun 30, 27
RBC Capital ↗
Jun 16, 26
▲ Outperform · 🎯$100
Price at call : $86.68 — upside +15%
Today : $89.95 — upside +11%
🎯 on EW : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Jun 16, 27
matures : Jun 16, 27
▲ Buy · 🎯$104
Price at call : $86 — upside +21%
Today : $89.95 — upside +16%
🎯 on EW : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Jun 2, 27
matures : Jun 2, 27
▲ Overweight · 🎯$110
Price at call : $82.28 — upside +34%
Today : $89.95 — upside +22%
🎯 on EW : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Apr 27, 27
matures : Apr 27, 27
Evercore ISI Group ↗
Apr 24, 26
▲ Outperform · 🎯$93
Price at call : $83.46 — upside +11%
Today : $89.95 — upside +3%
🎯 on EW : no call matured yet · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Apr 24, 27
matures : Apr 24, 27
Truist Securities ↗
Apr 24, 26
■ Hold neutral · not a buy · 🎯$90
Price at call : $83.46 — gap to target +8%
Today : $89.95 — gap to target +0%
🎯 on EW : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Apr 24, 27
matures : Apr 24, 27
Canaccord Genuity ↗
Apr 24, 26
■ Hold neutral · not a buy · 🎯$85
Price at call : $83.46 — gap to target +2%
Today : $89.95 — gap to target -6%
🎯 on EW : 67% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
in progress (365j)
matures : Apr 24, 27
matures : Apr 24, 27
▲ Buy · 🎯$100
Price at call : $84.15 — upside +19%
Today : $89.95 — upside +11%
🎯 on EW : no call matured yet · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Apr 24, 27
matures : Apr 24, 27
■ Neutral neutral · not a buy · 🎯$87
Price at call : $84.15 — gap to target +3%
Today : $89.95 — gap to target -3%
🎯 on EW : no call matured yet · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : Apr 24, 27
matures : Apr 24, 27
▲ Outperform · 🎯$95
Price at call : $78.2 — upside +21%
Today : $89.95 — upside +6%
🎯 on EW : no call matured yet · 📊 on Health : 52.1% · +3.5% (217 calls)
in progress (365j)
matures : Apr 13, 27
matures : Apr 13, 27
Evercore ISI Group ↗
Apr 6, 26
▲ Outperform · 🎯$92
Price at call : $80.84 — upside +14%
Today : $89.95 — upside +2%
🎯 on EW : no call matured yet · 📊 on Health : 45.8% · +0.0% (168 calls)
in progress (365j)
matures : Apr 6, 27
matures : Apr 6, 27
Goldman Sachs ↗
Feb 11, 26
▲ Buy · 🎯$95
Price at call : $76.44 — upside +24%
Today : $89.95 — upside +6%
🎯 on EW : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Feb 11, 27
matures : Feb 11, 27
Piper Sandler ↗
Feb 11, 26
▲ Overweight · 🎯$100
Price at call : $76.44 — upside +31%
Today : $89.95 — upside +11%
🎯 on EW : no call matured yet · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Feb 11, 27
matures : Feb 11, 27
Truist Securities ↗
Feb 11, 26
■ Hold neutral · not a buy · 🎯$89
Price at call : $76.44 — gap to target +16%
Today : $89.95 — gap to target -1%
🎯 on EW : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Feb 11, 27
matures : Feb 11, 27
Wells Fargo ↗
Feb 11, 26
▲ Overweight · 🎯$100
Price at call : $76.44 — upside +31%
Today : $89.95 — upside +11%
🎯 on EW : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Feb 11, 27
matures : Feb 11, 27
▲ Buy · 🎯$103
Price at call : $79.33 — upside +30%
Today : $89.95 — upside +15%
🎯 on EW : no call matured yet · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Feb 11, 27
matures : Feb 11, 27
▲ Buy · 🎯$110
Price at call : $85.14 — upside +29%
Today : $89.95 — upside +22%
🎯 on EW : no call matured yet · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Jan 20, 27
matures : Jan 20, 27
Piper Sandler ↗
Jan 20, 26
▲ Overweight · 🎯$98
Price at call : $83.46 — upside +17%
Today : $89.95 — upside +9%
🎯 on EW : no call matured yet · 📊 on Health : 46.7% · -1.3% (321 calls)
in progress (365j)
matures : Jan 20, 27
matures : Jan 20, 27
■ Neutral neutral · not a buy · 🎯$95
Price at call : $83.84 — gap to target +13%
Today : $89.95 — gap to target +6%
🎯 on EW : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Jan 12, 27
matures : Jan 12, 27
▲ Overweight · 🎯$104
Price at call : $83.84 — upside +24%
Today : $89.95 — upside +16%
🎯 on EW : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Jan 12, 27
matures : Jan 12, 27
▲ Buy · 🎯$97
Price at call : $83.01 — upside +17%
Today : $89.95 — upside +8%
🎯 on EW : no call matured yet · 📊 on Health : 49% · +1.0% (96 calls)
in progress (365j)
matures : Jan 9, 27
matures : Jan 9, 27
▲ Buy · 🎯$105
Price at call : $84.83 — upside +24%
Today : $89.95 — upside +17%
🎯 on EW : no call matured yet · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Jan 7, 27
matures : Jan 7, 27
▲ Overweight · 🎯$100
Price at call : $84.8 — upside +18%
Today : $89.95 — upside +11%
🎯 on EW : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Dec 18, 26
matures : Dec 18, 26
Canaccord Genuity ↗
Dec 17, 25
■ Hold neutral · not a buy · 🎯$87
Price at call : $84.8 — gap to target +3%
Today : $89.95 — gap to target -3%
🎯 on EW : 67% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
in progress (365j)
matures : Dec 17, 26
matures : Dec 17, 26
■ Neutral neutral · not a buy · 🎯$87
Price at call : $85.32 — gap to target +2%
Today : $89.95 — gap to target -3%
🎯 on EW : no call matured yet · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : Dec 16, 26
matures : Dec 16, 26
▲ Buy · 🎯$101
Price at call : $83.08 — upside +22%
Today : $89.95 — upside +12%
🎯 on EW : 42% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Dec 11, 26
matures : Dec 11, 26
▲ Overweight · 🎯$103
Price at call : $83.28 — upside +24%
Today : $89.95 — upside +15%
🎯 on EW : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Dec 8, 26
matures : Dec 8, 26
Canaccord Genuity ↗
Dec 5, 25
■ Hold neutral · not a buy · 🎯$89
Price at call : $84.32 — gap to target +6%
Today : $89.95 — gap to target -1%
🎯 on EW : 67% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
in progress (365j)
matures : Dec 5, 26
matures : Dec 5, 26
▲ Buy · 🎯$100
Price at call : $84.32 — upside +19%
Today : $89.95 — upside +11%
🎯 on EW : no call matured yet · 📊 on Health : 51.2% · +8.1% (299 calls)
in progress (365j)
matures : Dec 5, 26
matures : Dec 5, 26
■ Neutral neutral · not a buy · 🎯$92
Price at call : $84.32 — gap to target +9%
Today : $89.95 — gap to target +2%
🎯 on EW : no call matured yet · 📊 on Health : 51.5% · +3.1% (355 calls)
in progress (365j)
matures : Dec 5, 26
matures : Dec 5, 26
Wells Fargo ↗
Dec 5, 25
▲ Overweight · 🎯$96
Price at call : $84.32 — upside +14%
Today : $89.95 — upside +7%
🎯 on EW : no call matured yet · 📊 on Health : 48.5% · +1.2% (392 calls)
in progress (365j)
matures : Dec 5, 26
matures : Dec 5, 26
Truist Securities ↗
Dec 5, 25
■ Hold neutral · not a buy · 🎯$92
Price at call : $84.32 — gap to target +9%
Today : $89.95 — gap to target +2%
🎯 on EW : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Dec 5, 26
matures : Dec 5, 26
RBC Capital ↗
Dec 5, 25
▲ Outperform · 🎯$100
Price at call : $86.19 — upside +16%
Today : $89.95 — upside +11%
🎯 on EW : no call matured yet · 📊 on Health : 42.8% · -2.4% (395 calls)
in progress (365j)
matures : Dec 5, 26
matures : Dec 5, 26
■ Neutral neutral · not a buy · 🎯$88
Price at call : $86.19 — gap to target +2%
Today : $89.95 — gap to target -2%
🎯 on EW : no call matured yet · 📊 on Health : 51.7% · +6.5% (298 calls)
in progress (365j)
matures : Dec 5, 26
matures : Dec 5, 26
▲ Buy · 🎯$103
Price at call : $86.19 — upside +20%
Today : $89.95 — upside +15%
🎯 on EW : no call matured yet · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Dec 5, 26
matures : Dec 5, 26
▲ Buy · 🎯$100
Price at call : $86.82 — upside +15%
Today : $89.95 — upside +11%
🎯 on EW : no call matured yet · 📊 on Health : 54.8% · +8.3% (115 calls)
in progress (365j)
matures : Nov 25, 26
matures : Nov 25, 26
Truist Securities ↗
Nov 3, 25
■ Hold neutral · not a buy · 🎯$90
Price at call : $84.15 — gap to target +7%
Today : $89.95 — gap to target +0%
🎯 on EW : no call matured yet · 📊 on Health : 49.6% · +2.3% (260 calls)
in progress (365j)
matures : Nov 3, 26
matures : Nov 3, 26
Canaccord Genuity ↗
Nov 3, 25
■ Hold neutral · not a buy · 🎯$84
Price at call : $83.07 — gap to target +1%
Today : $89.95 — gap to target -7%
🎯 on EW : 67% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
in progress (365j)
matures : Nov 3, 26
matures : Nov 3, 26
▲ Overweight · 🎯$99
Price at call : $83.07 — upside +19%
Today : $89.95 — upside +10%
🎯 on EW : no call matured yet · 📊 on Health : 50.1% · +2.2% (629 calls)
in progress (365j)
matures : Oct 31, 26
matures : Oct 31, 26
▲ Buy · 🎯$96
Price at call : $83.07 — upside +16%
Today : $89.95 — upside +7%
🎯 on EW : 42% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
in progress (365j)
matures : Oct 31, 26
matures : Oct 31, 26
■ Neutral neutral · not a buy · 🎯$90
Price at call : $83.07 — gap to target +8%
Today : $89.95 — gap to target +0%
🎯 on EW : no call matured yet · 📊 on Health : 53.8% · +5.3% (355 calls)
in progress (365j)
matures : Oct 31, 26
matures : Oct 31, 26
Goldman Sachs ↗
Oct 31, 25
▲ Buy · 🎯$104
Price at call : $83.07 — upside +25%
Today : $89.95 — upside +16%
🎯 on EW : no call matured yet · 📊 on Health : 50.8% · +2.0% (240 calls)
in progress (365j)
matures : Oct 31, 26
matures : Oct 31, 26
▲ Buy · 🎯$95
Price at call : $74.99 — upside +27%
Today : $89.95 — upside +6%
Expected +27% · Actual +17% · Reason (≥ +15%) : ✓ Yes
🎯 on EW : 42% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
+16.7%
stock +17% · XLV +14%
matured May 22, 26
▲ Buy · 🎯$83
Price at call : $73.97 — upside +12%
Today : $89.95 — upside -8%
Expected +12% · Actual +12% · Reason (≥ +15%) : ✗ No
🎯 on EW : 42% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
+12.3%
stock +12% · XLV +9%
matured Dec 11, 25
▲ Buy · 🎯$77
Price at call : $65.15 — upside +18%
Today : $89.95 — upside -14%
Expected +18% · Actual +18% · Reason (≥ +15%) : ✓ Yes
🎯 on EW : 42% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
+17.6%
stock +18% · XLV -6%
matured Oct 1, 25
▲ Buy · 🎯$106
Price at call : $92.85 — upside +14%
Today : $89.95 — upside +18%
Expected +14% · Actual -16% · Reason (≥ +15%) : ✗ No
🎯 on EW : 42% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
-15.9%
stock -16% · XLV -8%
matured Jul 11, 25
▲ Buy · 🎯$105
Price at call : $90.21 — upside +16%
Today : $89.95 — upside +17%
Expected +16% · Actual -17% · Reason (≥ +15%) : ✗ No
🎯 on EW : 42% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
-17.1%
stock -17% · XLV -11%
matured May 22, 25
▲ Buy · 🎯$85
Price at call : $61.71 — upside +38%
Today : $89.95 — upside -6%
Expected +38% · Actual +11% · Reason (≥ +15%) : ✗ No
🎯 on EW : 42% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
+11.0%
stock +11% · XLV +21%
matured Oct 25, 24
▲ Buy · 🎯$94
Price at call : $69.6 — upside +35%
Today : $89.95 — upside +5%
Expected +35% · Actual -6% · Reason (≥ +15%) : ✗ No
🎯 on EW : 42% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
-6.4%
stock -6% · XLV +20%
matured Oct 1, 24
▲ Buy · 🎯$110
Price at call : $93.1 — upside +18%
Today : $89.95 — upside +22%
Expected +18% · Actual -0% · Reason (≥ +15%) : ✗ No
🎯 on EW : 42% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
-0.3%
stock -0% · XLV +14%
matured Jul 10, 24
▲ Buy · 🎯$101
Price at call : $87.98 — upside +15%
Today : $89.95 — upside +12%
Expected +15% · Actual -2% · Reason (≥ +15%) : ✗ No
🎯 on EW : 42% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
-2.3%
stock -2% · XLV +5%
matured Apr 26, 24
▲ Buy · 🎯$97
Price at call : $82.17 — upside +18%
Today : $89.95 — upside +8%
Expected +18% · Actual +15% · Reason (≥ +15%) : ✗ No
🎯 on EW : 42% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
+14.8%
stock +15% · XLV +10%
matured Apr 2, 24
▲ Buy · 🎯$92
Price at call : $75.32 — upside +22%
Today : $89.95 — upside +2%
Expected +22% · Actual -4% · Reason (≥ +15%) : ✗ No
🎯 on EW : 42% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
-4.2%
stock -4% · XLV -4%
matured Dec 12, 23
▲ Buy · 🎯$99
Price at call : $70.87 — upside +40%
Today : $89.95 — upside +10%
Expected +40% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on EW : 42% (12 calls matureds) · 📊 on Health : 53.1% · +2.5% (508 calls)
-12.0%
stock -12% · XLV -7%
matured Oct 28, 23
Canaccord Genuity ↗
Apr 27, 22
▲ Buy · 🎯$137
Price at call : $109.77 — upside +25%
Today : $89.95 — upside +52%
Expected +25% · Actual -20% · Reason (≥ +15%) : ✗ No
🎯 on EW : 67% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
-19.9%
stock -20% · XLV -0%
matured Apr 27, 23
Canaccord Genuity ↗
Jul 30, 21
▲ Buy · 🎯$124
Price at call : $113.28 — upside +9%
Today : $89.95 — upside +38%
Expected +9% · Actual -12% · Reason (≥ +15%) : ✗ No
🎯 on EW : 67% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
-12.2%
stock -12% · XLV -1%
matured Jul 30, 22
Canaccord Genuity ↗
Apr 21, 21
▲ Buy · 🎯$103
Price at call : $96.15 — upside +7%
Today : $89.95 — upside +15%
Expected +7% · Actual +23% · Reason (≥ +15%) : ✓ Yes
🎯 on EW : 67% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
+23.1%
stock +23% · XLV +9%
matured Apr 21, 22
Canaccord Genuity ↗
Dec 11, 20
▲ Buy · 🎯$94
Price at call : $83.57 — upside +12%
Today : $89.95 — upside +5%
Expected +12% · Actual +44% · Reason (≥ +15%) : ✓ Yes
🎯 on EW : 67% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
+44.5%
stock +44% · XLV +23%
matured Dec 11, 21
Canaccord Genuity ↗
Jul 24, 20
▲ Buy · 🎯$89
Price at call : $78.69 — upside +13%
Today : $89.95 — upside -1%
Expected +13% · Actual +38% · Reason (≥ +15%) : ✓ Yes
🎯 on EW : 67% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
+38.4%
stock +38% · XLV +23%
matured Jul 24, 21
Canaccord Genuity ↗
Jul 24, 19
▲ Buy · 🎯$83.3333
Price at call : $71.63 — upside +16%
Today : $89.95 — upside -7%
Expected +16% · Actual +8% · Reason (≥ +15%) : ✗ No
🎯 on EW : 67% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
+8.0%
stock +8% · XLV +15%
matured Jul 23, 20
Canaccord Genuity ↗
Sep 16, 14
▲ Buy · 🎯$19
Price at call : $16.83 — upside +13%
Today : $89.95 — upside -79%
Expected +13% · Actual +39% · Reason (≥ +15%) : ✓ Yes
🎯 on EW : 67% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
+39.2%
stock +39% · XLV +11%
matured Sep 16, 15
Canaccord Genuity ↗
May 22, 14
▲ Buy · 🎯$16
Price at call : $13.57 — upside +18%
Today : $89.95 — upside -82%
Expected +18% · Actual +61% · Reason (≥ +15%) : ✓ Yes
🎯 on EW : 67% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
+60.8%
stock +61% · XLV +27%
matured May 22, 15
Canaccord Genuity ↗
Apr 26, 14
▲ Buy · 🎯$14.3333
Price at call : $13.53 — upside +6%
Today : $89.95 — upside -84%
Expected +6% · Actual +61% · Reason (≥ +15%) : ✓ Yes
🎯 on EW : 67% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
+61.3%
stock +61% · XLV +27%
matured Apr 26, 15
Canaccord Genuity ↗
Oct 30, 13
▲ Buy · 🎯$12.6667
Price at call : $10.86 — upside +17%
Today : $89.95 — upside -86%
Expected +17% · Actual +85% · Reason (≥ +15%) : ✓ Yes
🎯 on EW : 67% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
+85.5%
stock +85% · XLV +27%
matured Oct 30, 14
Canaccord Genuity ↗
Feb 4, 13
▲ Buy · 🎯$19.1667
Price at call : $14.46 — upside +33%
Today : $89.95 — upside -79%
Expected +33% · Actual -23% · Reason (≥ +15%) : ✗ No
🎯 on EW : 67% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
-23.3%
stock -23% · XLV +27%
matured Feb 4, 14
Canaccord Genuity ↗
Oct 9, 12
▲ Buy · 🎯$18.1667
Price at call : $14.1 — upside +29%
Today : $89.95 — upside -80%
Expected +29% · Actual -14% · Reason (≥ +15%) : ✗ No
🎯 on EW : 67% (12 calls matureds) · 📊 on Health : 53% · +6.1% (151 calls)
-13.9%
stock -14% · XLV +23%
matured Oct 9, 13
Frequently asked questions
Should I buy Edwards Lifesciences stock?
This isn't buy advice. For Edwards Lifesciences, the analyst consensus is "Buy", with an average price target of $104 (+16% vs the current price). What matters is their past reliability on this stock: the most reliable one is right 100% of the time (2 calls tracked on Edwards Lifesciences). We show the numbers — you decide.
Is it too late to buy Edwards Lifesciences? How high can it go?
The most bullish analyst target on Edwards Lifesciences is $110 (+22% above today's price); the average is $104. That's the upside they see. Check how reliable those analysts have actually been on Edwards Lifesciences on our site before trusting it.
Is Edwards Lifesciences still a good buy?
The most useful "opinion" isn't an opinion — it's a track record: 30 analysts have a real record on Edwards Lifesciences, the best hitting 100% over 2 calls. Current consensus: "Buy". Make your call on data, not noise.
Should you invest in Edwards Lifesciences? The case for and against
The arguments for and against, one by one, from the numbers: why invest in EW (and why hesitate).
What has Edwards Lifesciences's past performance been?
Historical returns and a "how much if I had invested" calculator: EW performance & returns.
What is the best month to buy EW?
The 12 months ranked by the stock's past returns: best & worst month to buy EW.
BIIB 
VRTX 
UNH 
REGN 
SRPT 
VEEV 
BSX 
LLY